Sublocade, a monthly injectable alternative to the widely used opioid treatment Suboxone, has been approved by Health Canada after a small but so far successful run in the U.S. (Source: CBC | Health)

{ 0 comments }

Sublocade, an injectable alternative to Suboxone, has been approved by Health Canada after a successful run in the U.S. The treatment is administered once a month and is highly touted by many American physicians. (Source: CBC | Health)

{ 0 comments }

'I feel normal': health officials eye injectable opioid addiction treatment

January 17, 2019

Sublocade, an injectable alternative to Suboxone, has been approved by Health Canada after a successful run in the U.S. The treatment is administered once a month and is highly touted by many American physicians. (Source: CBC | Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with […]

Read the full article →

UPMC Health Plan training doctors to treat opioid-abuse disorder

December 22, 2018

Suboxone is a narcotic that can be used to treat addiction to narcotic pain relievers. But being able to prescribe the medication requires a waiver from the Drug Enforcement Agency. (Source: bizjournals.com Health Care:Physician Practices headlines) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social […]

Read the full article →

Indivior Plans Cheaper Opioid Addiction Drug if Rivals Launch Copycats Indivior Plans Cheaper Opioid Addiction Drug if Rivals Launch Copycats

December 20, 2018

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug.Reuters Health Information (Source: Medscape Medical News Headlines) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% […]

Read the full article →

Indivior plans cheaper opioid addiction drug to keep copycats at bay

December 19, 2018

Indivior Plc said it will launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, as it seeks to claw back market share lost to copycat versions of the drug. (Source: Reuters: Health)

Read the full article →

Indivior plans cheaper opioid addiction drug if rivals launch copycats

December 19, 2018

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug. (Source: Reuters: Health) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

December 18, 2018

MONDAY, Dec. 17, 2018 — Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine. Sean M. Murphy, Ph.D.,… (Source: Drugs.com – Pharma News) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log […]

Read the full article →

The Treatment Gap: This City ’ s Overdose Deaths Have Plunged. Can Others Learn From It?

December 12, 2018

Dayton, Ohio, had one of the highest overdose death rates in the nation in 2017. The city made many changes, and fatal overdoses are down more than 50 percent from last year. (Source: NYT Health)

Read the full article →

A Promising Way to Help Drug Users Is ‘Severely Lacking’ Around the World, Report Says

December 12, 2018

Global funding for harm reduction programs is in “crisis,” according to the latest Global State of Harm Reduction report, potentially threatening the effectiveness of HIV, hepatitis and drug overdose relief programs worldwide. Harm reduction policies and programs are meant to curb the negative effects associated with illicit drug use — such as overdoses and the […]

Read the full article →